<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452232</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">966</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13100966</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: The present study aims to highlight the possible significant changes due to the COVID-19 pandemic in the resistance of pathogens involved in cases of pediatric infections. <b>Methods</b>: This study included children hospitalized in the Pediatric Intensive Care Unit, Surgery and Pediatrics from a tertiary teaching hospital, during and after the COVID-19 period (2020-2023). <b>Results</b>: The research included 845 samples collected during 2020-2023, from 685 pediatric patients. A total of 937 bacterial isolates were obtained, of which 509 isolates (54.32%) were Gram-negative bacteria. Around 30% of all the pathogens were multidrug-resistant (MDR), with a statistically significant increase post-pandemic, in the case of the MDR <i>Escherichia coli</i> strains (<i>p</i> &lt; 0.05). A very high percentage of MDR <i>Acinetobacter</i> spp. isolates was found, with an important, but not statistically significant, increase in the post-pandemic period. The highest percentage of the MDR Gram-positive pathogens was registered in the case of <i>S. aureus</i> strains (31.80%). Over 20% of the <i>Coagulase-negative Staphylococci (CoNS)</i> strains isolated between 2020 and 2023 were MDR, with an important increase in the post-COVID-19 period. The proportion of carbapenem-resistant Gram-negative pathogens significantly decreased in the post-COVID-19 period compared with the COVID-19 period (<i>p</i> &lt; 0.05), especially in the case of the <i>Klebsiella</i> spp. strains. <b>Conclusions</b>: Our findings revealed the increase in the post-COVID-19 period of the prevalence of MDR strains of <i>Acinetobacter</i> spp., <i>CoNS</i>, and <i>Escherichia coli</i> isolated in pediatric patient samples and a significant decline in the trend of the carbapenem-resistant Gram-negative pathogens, which may be due to the testing rate and to the specific pathology of the pediatric patients hospitalized in the two periods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Golli</LastName><ForeName>Andreea-Loredana</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-1802-3601</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Management, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popa</LastName><ForeName>Simona Georgiana</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Diabetes, Nutrition and Metabolic Diseases, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cara</LastName><ForeName>Monica Laura</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-5471-4717</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Management, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoica</LastName><ForeName>George-Alin</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery and Orthopedics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortofoiu</LastName><ForeName>Dragos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoica</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">antimicrobial resistance</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">pathogens</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452232</ArticleId><ArticleId IdType="pmc">PMC11505055</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13100966</ArticleId><ArticleId IdType="pii">antibiotics13100966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Council of the European Union  Document 32023H0622(01): COUNCIL RECOMMENDATION on Stepping up EU Actions to Combat Antimicrobial Resistance in a One Health Approach (2023/C 220/01) 2023.  [(accessed on 2 September 2024)].  Available online:  https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32023H0622%2801%29.</Citation></Reference><Reference><Citation>Rehman S. A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic. J. Infect. Public Health. 2023;16:611–617. doi: 10.1016/j.jiph.2023.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.02.021</ArticleId><ArticleId IdType="pmc">PMC9942450</ArticleId><ArticleId IdType="pubmed">36857834</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC  35 000 Annual Deaths from Antimicrobial Resistance in the EU/EEA.  [(accessed on 7 September 2024)].  Available online:  https://www.ecdc.europa.eu/en/news-events/eaad-2022-launch.</Citation></Reference><Reference><Citation>ECDC . Antimicrobial Resistance in the EU/EEA (EARS-Net)—Annual Epidemiological Report 2022. ECDC; Stockholm, Sweden: 2023.</Citation></Reference><Reference><Citation>Tsouklidis N., Kumar R., Heindl S.E., Soni R., Khan S. Understanding the Fight Against Resistance: Hospital-Acquired Methicillin-Resistant Staphylococcus Aureus vs. Community-Acquired Methicillin-Resistant Staphylococcus Aureus. Cureus. 2020;12:e8867. doi: 10.7759/cureus.8867.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8867</ArticleId><ArticleId IdType="pmc">PMC7325383</ArticleId><ArticleId IdType="pubmed">32617248</ArticleId></ArticleIdList></Reference><Reference><Citation>Olteanu M., Nitu M., Golli A. Tuberculosis mesenteric adenopathy and polyserositis. Rom. J. Morphol. Embryol. 2012;53:835–840.</Citation><ArticleIdList><ArticleId IdType="pubmed">23188450</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. World Health Organization; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Romandini A., Pani A., Schenardi P.A., Pattarino G.A.C., De Giacomo C., Scaglione F. Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics. 2021;10:393. doi: 10.3390/antibiotics10040393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10040393</ArticleId><ArticleId IdType="pmc">PMC8067449</ArticleId><ArticleId IdType="pubmed">33917430</ArticleId></ArticleIdList></Reference><Reference><Citation>Pana Z.D., El-Shabrawi M., Sultan M.A., Murray T., Alam A., Yewale V., Dharmapalan D., Klein J.D., Haddad J., Thacker N., et al. Fighting the hidden pandemic of antimicrobial resistance in paediatrics: Recommendations from the International Pediatric Association. BMJ Paediatr. Open. 2023;7:e002084. doi: 10.1136/bmjpo-2023-002084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2023-002084</ArticleId><ArticleId IdType="pmc">PMC10387713</ArticleId><ArticleId IdType="pubmed">37500294</ArticleId></ArticleIdList></Reference><Reference><Citation>UNICEF  AMR: The Urgent Threat of Drug-Resistant Infections: Protecting Children Worldwide—A UNICEF Guidance Note on Antimicrobial Resistance. 2023.  [(accessed on 30 August 2024)].  Available online:  https://www.unicef.org/documents/amr-urgent-threat-drug-resistant-infections.</Citation></Reference><Reference><Citation>GBD 2021 Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. Lancet. 2024;404:1199–1226. doi: 10.1016/S0140-6736(24)01867-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01867-1</ArticleId><ArticleId IdType="pubmed">39299261</ArticleId></ArticleIdList></Reference><Reference><Citation>INSP . CARMIAAM-ROM 2020 (Consumul de Antibiotice, Rezistența Microbiană și Infecții Asociate Asistenței Medicale în România—2020. INSP; Bucuresti, Romania: 2020.</Citation></Reference><Reference><Citation>Prajescu B., Gavriliu L., Iesanu M.I., Ioan A., Boboc A.A., Boboc C., Galos F. Bacterial Species and Antibiotic Resistance-A Retrospective Analysis of Bacterial Cultures in a Pediatric Hospital. Antibiotics. 2023;12:966. doi: 10.3390/antibiotics12060966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12060966</ArticleId><ArticleId IdType="pmc">PMC10294880</ArticleId><ArticleId IdType="pubmed">37370285</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi F.A., Hegazi M.A., Alsaedi H., Alganmi A.H., Mokhtar J.A., Metwalli E.M., Hamadallah H., Siam G.S., Alaqla A., Alsharabi A., et al. Multidrug-Resistant Bacterial Infections in Pediatric Patients Hospitalized at King Abdulaziz University Hospital, Jeddah, Western Saudi Arabia. Children. 2024;11:444. doi: 10.3390/children11040444.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children11040444</ArticleId><ArticleId IdType="pmc">PMC11049043</ArticleId><ArticleId IdType="pubmed">38671661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibi D., Sethi D.C., Jibin V.G., Silvanose C.D. Emerging Antibiotic Resistance in Post-COVID-19 Co-infections. J. Clin. Med. Case Rep. 2023;8:8.</Citation></Reference><Reference><Citation>Kishk R.M., Abu Bakr N.M., Anani M., Nemr N., Salama B.M., Samahy M., Kishk S.M., Salem N.E., Mohamed H.A. Pattern of antimicrobial resistance in the pre and during COVID-19 era: An observational study. Microbes Infect. Dis. 2023;4:1100–1113. doi: 10.21608/mid.2023.217092.1539.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/mid.2023.217092.1539</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezk A.R., Bawady S.A., Omar N.N. Incidence of emerging multidrug-resistant organisms and its impact on the outcome in the pediatric intensive care. Egypt. Pediatr. Assoc. Gaz. 2021;69:25. doi: 10.1186/s43054-021-00071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43054-021-00071-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani N.A., Alebouyeh M., Azimi L., Jabbari S., Bayekolaei R.M., Azimi T., Ghandchi G., Maham S., Fallah F. Bacteremia with Multi-drug Resistant Gram-negative Bacteria in Pediatrics and Its Correlation with COVID-19. Arch. Clin. Infect. Dis. 2023;18:e136159. doi: 10.5812/archcid-136159.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/archcid-136159</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan L.K. Carbapenem-resistant enterobacteriaceae: An emerging problem in children. Clin. Infect. Dis. 2012;55:852–859. doi: 10.1093/cid/cis543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis543</ArticleId><ArticleId IdType="pubmed">22700827</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Jorge G., Rodrigues Dos Santos Goes I.C., Gontijo M.T.P. Les miserables: A Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developing Countries. Curr. Infect. Dis. Rep. 2022;24:175–186. doi: 10.1007/s11908-022-00788-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-022-00788-z</ArticleId><ArticleId IdType="pmc">PMC9531231</ArticleId><ArticleId IdType="pubmed">36211535</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC. WHO . Antimicrobial Resistance Surveillance in Europe 2023–2021 Data. ECDC; Stockholm, Sweden: 2023.</Citation></Reference><Reference><Citation>Golli A.L., Zlatian O.M., Cara M.L., Olteanu M. Pre- and Post-COVID-19 Antimicrobial Resistance Pattern of Pathogens in an Intensive Care Unit. Pharmaceuticals. 2024;17:407. doi: 10.3390/ph17040407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph17040407</ArticleId><ArticleId IdType="pmc">PMC11054378</ArticleId><ArticleId IdType="pubmed">38675369</ArticleId></ArticleIdList></Reference><Reference><Citation>Golli A.L., Nitu F.M., Balasoiu M., Nemes R.M., Tudorache S.I., Mahler Boca B., Olteanu M. Bacterial Isolates from Endotracheal Aspirates and their Antimicrobial Resistance Pattern in Patients from Intensive Care Unit. Rev. Chim. 2019;70:3299–3304. doi: 10.37358/RC.19.9.7538.</Citation><ArticleIdList><ArticleId IdType="doi">10.37358/RC.19.9.7538</ArticleId></ArticleIdList></Reference><Reference><Citation>Golli A.L., Nitu F.M., Balasoiu M., Lungu M.A., Dragomirescu C.C., Olteanu M., Nemes R.M., Tantu M.M., Olteanu M. The Characterization of Antibiotic Resistance of Bacterial Isolates from Intensive Care Unit Patient Samples in a University Affiliated Hospital in Romania. Rev. Chim. 2019;70:1778–1783. doi: 10.37358/RC.19.5.7214.</Citation><ArticleIdList><ArticleId IdType="doi">10.37358/RC.19.5.7214</ArticleId></ArticleIdList></Reference><Reference><Citation>Golli A.L.N., Nițu F.M., Balasoiu M., Rascu S., Lungu M.A., Dinescu S.N., Ciobanu Mitrache L., Glodeanu A., Vacaru M., Olteanu M. Microbiological profile and antibiotic resistance pattern of bacterial uropathogens among hospitalized patients. Farmacia. 2019;67:167–173. doi: 10.31925/farmacia.2019.1.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.31925/farmacia.2019.1.23</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghenea A.E., Cioboata R., Drocas A.I., Tieranu E.N., Vasile C.M., Morosanu A., Tieranu C.G., Salan A.I., Popescu M., Turculeanu A., et al. Prevalence and Antimicrobial Resistance of Klebsiella Strains Isolated from a County Hospital in Romania. Antibiotics. 2021;10:868. doi: 10.3390/antibiotics10070868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10070868</ArticleId><ArticleId IdType="pmc">PMC8300768</ArticleId><ArticleId IdType="pubmed">34356789</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkhy H.H., El-Saed A., Alshamrani M.M., Alsaedi A., Nasser W.A., Gammal A.E., Aljohany S.M., Arabi Y., Alqahtani S., Bonnie H.B., et al. High Burden of Resistant Gram Negative Pathogens Causing Device-associated Healthcare Infections in a Tertiary Care Setting in Saudi Arabia, 2008–2016. J. Glob. Antimicrob. Resist. 2020;23:26–32. doi: 10.1016/j.jgar.2020.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2020.07.013</ArticleId><ArticleId IdType="pubmed">32721564</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbu I.C., Gheorghe-Barbu I., Grigore G.A., Vrancianu C.O., Chifiriuc M.C. Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors. Int. J. Mol. Sci. 2023;24:7892. doi: 10.3390/ijms24097892.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24097892</ArticleId><ArticleId IdType="pmc">PMC10178704</ArticleId><ArticleId IdType="pubmed">37175597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A.J., Tamma P.D. Treatment of multidrug-resistant Gram-negative infections in children. Clin. Infect. Dis. 2014;58:1439–1448. doi: 10.1093/cid/ciu069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu069</ArticleId><ArticleId IdType="pubmed">24501388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu P., Wang C., Yu H., Wu X., Xu H., Jing C., Deng J., Wang H., Hua C., Chen Y., et al. Antimicrobial resistance profile of clinical strains isolated from children in China: A report from the ISPED program in 2021. Chin. J. Evid.-Based Pediatr. 2022;17:355–362.</Citation></Reference><Reference><Citation>Sajedi Moghaddam S., Mamishi S., Pourakbari B., Mahmoudi S. Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: A 5-year experience in an Iranian referral hospital. BMC Infect. Dis. 2024;24:373. doi: 10.1186/s12879-024-09260-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09260-w</ArticleId><ArticleId IdType="pmc">PMC10988941</ArticleId><ArticleId IdType="pubmed">38565980</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G., Schiavone F., Pipitone G., Taglietti F., Petrosillo N. Antibiotics Use in COVID-19 Patients: A Systematic Literature Review. J. Clin. Med. 2022;11:7207. doi: 10.3390/jcm11237207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11237207</ArticleId><ArticleId IdType="pmc">PMC9739751</ArticleId><ArticleId IdType="pubmed">36498781</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal S., Hussain S.S. Impact of COVID-19 Pandemic on Antimicrobial Resistance Pattern; Transition from Resistivity to Susceptibility. Glob. J. Med. Pharm. Biomed. Update. 2022;17:6. doi: 10.25259/GJMPBU_8_2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/GJMPBU_8_2022</ArticleId></ArticleIdList></Reference><Reference><Citation>Taleb M.H., Elmanama A.A., Taleb A.H., Tawfick M.M. Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital. J. Infect. Dev. Ctries. 2023;17:597–609. doi: 10.3855/jidc.17791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.17791</ArticleId><ArticleId IdType="pubmed">37279421</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisini A., Boni S., Vacca E.B., Bobbio N., Puente F.D., Feasi M., Prinapori R., Lattuada M., Sartini M., Cristina M.L., et al. Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center. Antibiotics. 2023;12:1278. doi: 10.3390/antibiotics12081278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12081278</ArticleId><ArticleId IdType="pmc">PMC10451647</ArticleId><ArticleId IdType="pubmed">37627698</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoofi R., Namavari N., Rahmanian V., Dousthaghi M.H. Evaluation of antibiotics resistance in Southern Iran in light of COVID-19 pandemic: A retrospective observational study. Health Sci. Rep. 2023;6:e1153. doi: 10.1002/hsr2.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1153</ArticleId><ArticleId IdType="pmc">PMC10017310</ArticleId><ArticleId IdType="pubmed">36938144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Wang C., He L., Xu H., Jing C., Chen Y., Lin A., Deng J., Cao Q., Deng H., et al. Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016–2021. Front. Cell. Infect. Microbiol. 2023;13:1102779. doi: 10.3389/fcimb.2023.1102779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1102779</ArticleId><ArticleId IdType="pmc">PMC9892648</ArticleId><ArticleId IdType="pubmed">36743309</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccabella L., Palma E.G., Abenavoli L., Scarlata G.G.M., Boni M., Ianiro G., Santori P., Tack J.F., Scarpellini E. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics. 2024;13:233. doi: 10.3390/antibiotics13030233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030233</ArticleId><ArticleId IdType="pmc">PMC10967554</ArticleId><ArticleId IdType="pubmed">38534668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mares C., Petca R.C., Petca A., Popescu R.I., Jinga V. Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm? Antibiotics. 2022;11:376. doi: 10.3390/antibiotics11030376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11030376</ArticleId><ArticleId IdType="pmc">PMC8944623</ArticleId><ArticleId IdType="pubmed">35326839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee N., Nirwan P.K., Srivastava S., Rati R., Sharma L., Sharma P., Dwivedi P., Jaggi N. Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India. Ann. Clin. Microbiol. Antimicrob. 2023;22:1. doi: 10.1186/s12941-022-00549-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-022-00549-9</ArticleId><ArticleId IdType="pmc">PMC9808733</ArticleId><ArticleId IdType="pubmed">36597098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A.G., Glodeanu A.D., Ionescu M., Zaharie S.I., Ciurea A.M., Golli A.L., Mavritsakis N., Popa D.L., Vere C.C. Clinical impact of wireless capsule endoscopy for small bowel investigation (Review) Exp. Ther. Med. 2022;23:262. doi: 10.3892/etm.2022.11188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11188</ArticleId><ArticleId IdType="pmc">PMC8892621</ArticleId><ArticleId IdType="pubmed">35251328</ArticleId></ArticleIdList></Reference><Reference><Citation>Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03570.x</ArticleId><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>INSP-CNSCBT  Sentinel Surveillance Methodology for Healthcare Associated Infections and Antimicrobial Resistance. 2018.  [(accessed on 15 December 2018)].  Available online:  https://www.cnscbt.ro.</Citation></Reference><Reference><Citation>Zlatian O., Balasoiu A.T., Balasoiu M., Cristea O., Docea A.O., Mitrut R., Spandidos D.A., Tsatsakis A.M., Bancescu G., Calina D. Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections. Exp. Ther. Med. 2018;16:4499–4510. doi: 10.3892/etm.2018.6737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6737</ArticleId><ArticleId IdType="pmc">PMC6257814</ArticleId><ArticleId IdType="pubmed">30542398</ArticleId></ArticleIdList></Reference><Reference><Citation>CLSI . Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI; Berwyn, PA, USA: 2020. CLSI Supplement, M100.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>